Cobicistat

surface glycoprotein ; Severe acute respiratory syndrome coronavirus 2







1 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 35229634 The FDA-Approved Drug Cobicistat Synergizes with Remdesivir To Inhibit SARS-CoV-2 Replication In Vitro and Decreases Viral Titers and Disease Progression in Syrian Hamsters. 2022 Apr 26 1